CON-INSULA: Structural Cartography of the Insula in Temporal Epilepsy Patients

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04871555
Collaborator
Centre de Recherche du Centre Hospitalier de l'Université de Montréal (Other), University Hospital, Lille (Other), Hospices Civils de Lyon (Other)
115
1
19
6.1

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate insula structural connectivity in temporal epilepsy patients. Insula being at the interface of frontal, parietal, occipital and temporal lobes, its structural organization reflects the brain function. We hypothetize that insular structural organization will be different according to the different subtypes of temporal epilepsy.

Condition or Disease Intervention/Treatment Phase
  • Other: MRI

Detailed Description

The purpose of this study is to investigate insula structural connectivity in temporal epilepsy patients. Insula being at the interface of frontal, parietal, occipital and temporal lobes, its structural organization reflects the brain function. We hypothetize that insular structural organization will be different according to the different subtypes of temporal epilepsy.

Study Design

Study Type:
Observational
Anticipated Enrollment :
115 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Structural Cartography of the Insula in Temporal Epilepsy Patients
Anticipated Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Apr 30, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
mesio-temporal epilepsy

patients suffering from mesiotemporal epilepsy type

Other: MRI
structural imaging

basal temporal epilepsy

patients suffering from basal temporal epilepsy type

Other: MRI
structural imaging

temporal lateral epilepsy

patients suffering from temporal lateral epilepsy type

Other: MRI
structural imaging

operculo insular epilepsy

patients suffering from operculo insular epilepsy type

Other: MRI
structural imaging

temporo-insular epilepsy

patients suffering from temporo- insular epilepsy type

Other: MRI
structural imaging

healthy subjects

non epileptic patients

Other: MRI
structural imaging

Outcome Measures

Primary Outcome Measures

  1. cartography of insula in temporal epilepsy patients [1 year after the last inclusion]

    Compared with healthy group, definition of different patterns of insular structural connectivity in epileptic patients

Secondary Outcome Measures

  1. Correlation structural cartography and electroclinical data [1 year after the last inclusion]

    correlation between patterns of insular structural connectivity and subtypes of epilepsy defined by electroclinical data

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • epileptic patients: temporal epilepsy or temporal plus epilepsy (temporomesial epilepsy, basal temporal epilepsy, mesio lateral or lateral epilepsy, temporo insular epilepsy, operculo insular epilepsy)

  • patients who underwent video EEG monitoring with recorded seizures (at least one)

  • patients who underwent a brain MRI with DTI sequence before epilepsy surgery

  • patients who did not refuse the use of their clinical and MRI data for this study

Exclusion Criteria:
  • patients younger than 15 years old

  • patients with previous brain surgery (before MRI)

  • uncompleted MRI sequences (DTI, T1 anatomical)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Central Hospital nancy Nancy France 54000

Sponsors and Collaborators

  • Central Hospital, Nancy, France
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal
  • University Hospital, Lille
  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: Louise Tyvaert, MD PHD, CHRU Nancy, CRAN UMR 7039 Université de Lorraine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TYVAERT Louise, Principal Investigator, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT04871555
Other Study ID Numbers:
  • 2020PI218
First Posted:
May 4, 2021
Last Update Posted:
May 4, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by TYVAERT Louise, Principal Investigator, Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2021